CT colonography screening: ready for prime time?

Area of Science:

• Medical Imaging
• Gastroenterology
• Oncology

Background:

• Colorectal cancer is a leading cause of cancer death worldwide, with over one million new cases annually.
• Screening and polyp removal significantly reduce colon cancer mortality, yet screening compliance is low.
• Optical colonoscopy is the standard screening method, but patient acceptance can be a barrier.

Purpose of the Study:

• To evaluate the readiness of computed tomography colonography (CTC) as a routine colorectal cancer screening test.
• To address the reservations of the Centers for Medicare and Medicaid Services (CMS) regarding CTC coverage.
• To compare the diagnostic performance of CTC with optical colonoscopy for adenomatous polyps.

Main Methods:

• Review of recent computed tomography colonography (CTC) trials.
• Analysis of CTC sensitivity and specificity for detecting adenomatous polyps (≥6 mm and ≥10 mm).
• Comparison of CTC performance against established optical colonoscopy benchmarks.

Main Results:

• CTC trials demonstrate high sensitivity for detecting adenomatous polyps, comparable to optical colonoscopy.
• CTC can identify polyps ≥10 mm and often ≥6 mm with high accuracy.
• Expert panels have recommended CTC as a viable colorectal cancer screening option.

Conclusions:

• CTC shows significant promise as an accurate and effective colorectal cancer screening tool.
• Despite demonstrated efficacy and expert endorsements, challenges remain in achieving widespread acceptance and coverage.
• Further evaluation and policy discussions are needed to determine the routine use of CTC in cancer screening programs.